FDA
-
-
-
-
-
-
-
Telix Announces Collaborations to Explore PSMA-PET Imaging in Emerging Prostate Cancer Treatment Approaches
-
-
-
-
-
-
-
Stifel Starts Profound Medical Corp. (PROF) at Hold, 'Still Work Ahead to Drive Broad Adoption'
-
-
-
-
-
-
-
Profound Medical to Release First Quarter 2023 Financial Results on May 10 – Conference Call to Follow
-
-
-
-
-
-
-
Profound Medical to Release Third Quarter 2022 Financial Results on November 3 – Conference Call to Follow
-
-
-
-
-
-
-
Profound Medical to Participate in the Cowen 7th Annual FutureHealth Conference
-
-
-
-
-
-
-
Profound Medical to Participate in the 2022 Bloom Burton & Co. Healthcare Investor Conference
-
-
-
-
-
-
-
Profound Medical Announces First Patients Treated in Prospective, Randomized Clinical Trial Comparing the TULSA Procedure to Radical Prostatectomy
-
330,878 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

